Navigation Links
AACR-NCI-EORTC to hold molecular targets meeting in San Francisco
Date:11/9/2011

SAN FRANCISCO -- Progress in oncology drug development will take center stage Nov. 12-16, 2011, as thousands of scientists and industry experts convene at the Moscone Center West in San Francisco for the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics.

"During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer," said program co-chairperson Kenneth C. Anderson, M.D., Kraft Family professor of medicine and program director and chief of the division of hematologic neoplasia at Dana-Farber Cancer Institute and Harvard Medical School. "The level of excitement surrounding targeted therapy and the high caliber of the science to be presented fuel the power of this meeting to attract the world's leaders in cancer therapeutics."

Anderson, who is also editor in chief of Clinical Cancer Research, a journal of the American Association for Cancer Research, will host a press conference on new research in breast cancer at 7:00 a.m. PT on Sunday, Nov. 12.

The press conference will feature the following research:

HDAC Inhibitor May Overcome Resistance to Common Breast Cancer Drug

Benefit of Novel Drug in Breast Cancer Seen in Blood Within Weeks

Signaling Pathway Linked to Inflammatory Breast Cancer May Drive Disease Metastasis

On Nov. 12 at 11:00 a.m. PT, program co-chairperson James H. Doroshow, M.D., FACP, deputy director for clinical and translational research at the National Cancer Institute, will host a press conference on progress in angiogenesis.

The press conference will feature the following research:

Researchers Develop More Effective Way to Discover and Test Potential Cancer Drugs

Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy

Combination Therapy Shows Potent Tumor Growth Inhibition in Preclinical Studies

Both press conferences will take place in Room 2004 of the Moscone Center. Reporters who cannot attend in person can call in using the following information:

U.S./Canada: 888-647-7462

International: 201-604-0169

In addition to the press conference, the program chairpersons have designated the following research projects as newsworthy:

Antifolates Show Promise Against NSCLC Subtype

New Approaches May Prevent Certain Side Effects in BRAF Mutation-Positive Melanoma

Panel of Melanoma Mutations Opens Door to New Treatment Possibilities


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Molecular pathways linked to sex, age affect outcomes in lung cancer
2. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
3. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
4. The Association for Molecular Pathology celebrates ruling in DNA patent case
5. USC researchers discover new molecular subtype of brain cancer
6. Molecular discovery points to new therapies for brain tumors
7. Molecular marker could help spot pancreatic cancer early
8. News from Molecular Medicine
9. Scientists discover the molecular heart of collective behavior
10. Salt Lake City proclaims Molecular Imaging Days during SNMs Annual Meeting in June
11. Acupunctures molecular effects pinned down
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: